SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-001639
Filing Date
2020-03-20
Accepted
2020-03-20 12:00:24
Documents
7
Period of Report
2020-05-01
Effectiveness Date
2020-03-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241011zdef14a.htm DEF 14A 519324
2 G1021959.JPG g1021959.jpg GRAPHIC 16596
3 G263414.JPG g263414.jpg GRAPHIC 5291
4 G944534.JPG g944534.jpg GRAPHIC 4276
5 G189424.JPG g189424.jpg GRAPHIC 3037
6 G17412BGI001.GIF g17412bgi001.gif GRAPHIC 93505
7 G17412BGI002.GIF g17412bgi002.gif GRAPHIC 105928
  Complete submission text file 0001047469-20-001639.txt   836105
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: DEF 14A | Act: 34 | File No.: 001-35024 | Film No.: 20731023
SIC: 2833 Medicinal Chemicals & Botanical Products